QNCX logo

QNCX Quince Therapeutics, Inc.

NASDAQ Global Select · Biotechnology · Healthcare

$31.73
+2.37 (+8.07%)

Quince Therapeutics, Inc. (QNCX) operates as a biopharmaceutical firm dedicated to developing targeted treatments for debilitating and rare diseases. A cornerstone of their innovation is an extensive bone-targeting drug delivery platform, engineered to accurately transport diverse therapeutic agents, such as small molecules, peptides, and large molecules, directly to affected bone areas like fract…

Market Cap: $8.83Mwww.quincetx.com

Price

No data yet.

Social Signal Score

62
5d
—
30d
—
60d
63
3 mentions
—
90d
60
4 mentions
—
news: 4

Analyst Ratings

5 analysts
Buyconsensus
Strong Buy 0Buy 4Hold 1Sell 0Strong Sell 0
Avg price target$70+120.6%
Low $68Median $70High $72
Current Consensus

Revenue

$0.00
$0.00
Mar 2018Sep 2026

Analyst Estimates

FY2025
$-218.84
$-218.84–$-218.84
1 analysts
FY2026
$-8.88
$-9.29–$-8.46
4 analysts
FY2027
$-4.68
$-4.86–$-4.49
4 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Brigette Roberts
Sector
Healthcare
Industry
Biotechnology
Employees
38
Beta
1.33
Country
US
Piotroski score
2 / 9 (Weak)
Altman Z-score
-7.94
www.quincetx.com